Granite Point Capital Management, L.P. Cue Biopharma, Inc. Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding CUE
# of Institutions
78Shares Held
16.3MCall Options Held
12.9KPut Options Held
39.1K-
Bleichroeder LP New York, NY2.76MShares$2.7 Million1.61% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$2.35 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$2.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.24MShares$2.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA839KShares$821,7600.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $34.7M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...